Where does public funding for HIV prevention go to? The case of condoms versus microbicides and vaccines
Tóm tắt
This study analyses the priorities of public donors in funding HIV prevention by either integrated condom programming or HIV preventive microbicides and vaccines in the period between 2000 and 2008. It further compares the public funding investments of the USA government and European governments, including the EU, as we expect the two groups to invest differently in HIV prevention options, because their policies on sexual and reproductive health and rights are different. We use two existing officially UN endorsed databases to compare the public donor funding streams for HIV prevention of these two distinct contributors. In the period 2000-2008, the relative share of public funding for integrated condom programming dropped significantly, while that for research on vaccines and microbicides increased. The European public donors gave a larger share to condom programming than the United States, but exhibited a similar downward trend in favour of funding research on vaccines and microbicides. Both public donor parties invested progressively more in research on vaccines and microbicides rather than addressing the shortage of condoms and improving access to integrated condom programming in developing countries.
Tài liệu tham khảo
UNAIDS, WHO: HIV epidemic update. Geneva. 2009
Antonio Izazola-Licea J, Wiegelmann J, Arán C, Guthrie T, Lay P, Avila-Figueroa C: Financing the response to HIV in low-income and middle-income countries. Journal of Acquired Immune Deficiencies Syndromes. 2009, 52 (Suppl): 119-126. 10.1097/QAI.0b013e3181baeeda.
Bertozzi SM, Laga M, Bautista-Arredondo S, Coutinho A: Making HIV prevention programmes work. The Lancet. 2008, 372 (9641): 831-844. 10.1016/S0140-6736(08)60889-2.
Haslegrave M: Implementing the ICPD Programme of Action. What a difference a decade makes. Reproductive Health Matters. 2004, 12 (23): 12-18. 10.1016/S0968-8080(04)23131-7.
Kumaranayake L, Watts C: Resource allocation and priority setting of HIV/HIV interventions: addressing the generalized epidemic in sub-Saharan Africa. Journal of International Development. 2001, 13: 451-466. 10.1002/jid.797.
Over M: Prevention Failure: The Ballooning Entitlement Burden of U.S. Global HIV Treatment Spending and What to Do About It. 2008, Washington: Center for Global Development Working Paper 144
Global fund against AIDS, Tuberculosis and Malaria: Progress Report Global. Geneva. 2010
Schwartländer B, Grubb I, Perriens J: The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world. The Lancet. 2006, 368: 541-546.
Global HIV Prevention Working Group: Factsheet Proven HIV prevention strategies. 2006, [http://www.globalhivprevention.org]
Coates TJ, Richter L, Caceres C: Behavioural strategies to reduce HIV transmission: how to make them work better. The Lancet. 2008, 372 (9639): 669-684. 10.1016/S0140-6736(08)60886-7.
Sidibé M, Buse K: Fomenting a prevention revolution for HIV. The Lancet. 2010, 375: 533-
Horton R: HIV: the elusive vaccine. New York Review of Books. 2004, 51: 53-57.
National Institute of Allergy and Infectious Diseases: NIH Science Daily HIV Vaccine Trial Cancelled. Bethesda. 2008
Stephenson J: Microbicide trial stopped. The Journal of the American Medical Association. 2007, 297: 1182-
Kapiga S, Hayes R, Buvé A: HIV prevention - where now? Background and introduction. AIDS. 2010, 24 (Suppl 4): S1-S3. 10.1097/01.aids.0000390702.50889.bb.
Evans D: Microbicide success story: what it means and where we go next. AIDSMEDS. 2010, [http://www.poz.com/articles/hiv_caprisa_microbicide_761_18794.shtml]
Population Action International: PAI report card. Condoms count. Washington. 2002
Carey RF, Herman WA, Retta RS, Rinaldi JE, Herman BA, Athey TW: Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sexually Transmitted Diseases. 1992, 19: 230-234. 10.1097/00007435-199207000-00009.
UNFPA, UNFPA and WHO: Joint position statement on condoms. Geneva. 2009
HIV-2031 costs and financing working group: PowerPoint presentation. Resource allocation and priority setting. Geneva. 2008
Demaria LM, Bautista-Arredondo SA, Galárraga O: What works to prevent and treat HIV. A review of cost-effectiveness literature with a long-term perspective. HIV 2031 Working Paper No. 27. Cuernavaca. 2007
UNFPA: Summary of the ICPD Programme of Action. 1995, New York: United Nations Department of Public Information
UNAIDS: UNGASS Declaration of commitment on HIV/AIDS. 2001, New York: United Nations Department of Public Information
United Nations Development Programme: Investing in Development. A practical plan to achieve the MDG. 2005, New York: United Nations Millennium project
UNFPA: Donor support for contraceptives and condoms for STI/HIV prevention. Annual report. 2009, New York: UNFPA commodity security branch
Peters A, Jansen W, Van Driel F: The female condom: the international denial of a strong potential. Reproductive Health Matters. 2010, 18 (35): 119-128. 10.1016/S0968-8080(10)35499-1.
Albarracin D, Kumkale GT, Johnson BT: Influences of social power and normative support on condom use decisions: a research synthesis. HIV Care. 2004, 16: 700-723.
Bedimo AL, Pinkerton SD, Cohen DA, Gray B, Farley TA: Condom distribution: a cost-utility analysis. International Journal of STD&HIV. 2002, 13: 384-
Creese A, Floyd K, Alban A, Guinness L: Cost-effectiveness of HIV/HIV interventions in Africa: a systematic review of the evidence. The Lancet. 2002, 359: 1635-1642. 10.1016/S0140-6736(02)08595-1.
Management Sciences for Health: The manager: Integrating STD/HIV service in Reproductive Health settings. Boston. 1998
Pinkerton SD, Abramson PR: Effectiveness of condoms in prevention HIV transmission. Social Science and Medicine. 1997, 44 (9197): 1303-1312.
Foss AM, Hossain M, Vickerman PT, Watts CH: A systematic review of published evidence on intervention impact on condom use in sub- Saharan Africa and Asia. Sexual Transmitted Infections. 2007, 83: 510-516. 10.1136/sti.2007.027144.
Weller SC, Davis-Beatty K: Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Systematic Reviews. 2007, 4:
Cohen D, Scribner R, Bedimo R, Farley T: Cost as a barrier to condom use: the evidence for condom subsidies in the United States. American Journal of Public Health. 1999, 89: 567-568. 10.2105/AJPH.89.4.567.
UNAIDS: Outlook report. Geneva. 2010, [http://data.unaids.org/pub/Report/2009/jc1796_outlook_en.pdf]
Gregson S, Todd J, Basia Z: Sexual behaviour change in countries with generalised HIV epidemics?. Sexual Transmitted Infections. 2009, 85 (Suppl1): 41-48.
UNAIDS, WHO: Progress in male circumcision scale-up: country implementation and research update. Geneva. 2010
WHO: Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva. 2004
Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH: Implementation science of pre-exposure prophylaxis: preparing for public use. Current HIV/AIDS Reports. 2010, 7: 210-219. 10.1007/s11904-010-0062-4.
Kippax S: Reasserting the social in a biomedical epidemic: The case of HIV-Prevention. 2010, London: Social Policy Research Centre
Heise LL, Watts C, Foss A, Trussell J, Vickerman P, Hayes R, McCormack S: Apples and oranges? Interpreting succession HIV prevention trials. Contraception. 2011, 83: 10-15. 10.1016/j.contraception.2010.06.009.
The Henry J. Kaiser Family Foundation and UNAIDS: Financing the reponse to HIV in low- and middle-income countries: International Assistance from the G8, European Commission and Other Donor Governments in 2008. Washington. 2009
Claeys V, Wuyts E: Official development assistance levels and spending on sexual and reproductive health and rights since the ICPD. The new demographic regime. 2005, United Nations Report. New York and Geneva: UNFPA and UNECE, 199-250.
European Council: World AIDS day. EU Statement on HIV prevention for an HIV free generation. Brussels. 2005
Boonstra H: Public health advocates say campaign to disparage condoms threatens STD prevention efforts. 2003, New York: The Guttmacher Report on Public Policy
Evertz SH: How ideology trumped science. Why PEPFAR has failed to meet its potential. 2010, Washington: Center for American Progress and the Council for Global Equity, 1-41.
HIV vaccine microbicide resource tracking group: Annual Report, Advancing the science in a time of fiscal constraint: Funding for HIV prevention technologies in 2009. Geneva. 2010
UNFPA and Netherlands Interdisciplinary Demographic Institute (NIDI): Report of the secretary general of the UN Economic Commission on Population and Development 43rd session. Flow of financial resources for assisting in the implementation of the programme of action of the ICPD. New York. 2010
Population Action International: Factsheet: Are nations meeting commitments to fund reproductive health? Washington. 2007
Shelton J, Johnston B: Condom gap in Africa: evidence from donor agencies and key informants. British Medical Journal. 2001, 323: 139-10.1136/bmj.323.7305.139.
UNFPA: Donor support for contraceptives and condoms for STI/HIV prevention. New York. 2001
UNFPA: Donor support for contraceptives and condoms for STI/HIV prevention. New York. 2007
Reproductive Health Supplies Coalition: Contraceptive Projections and the Donor Gap: Meeting the Challenge. Brussels. 2009
Poly Tech Synergies LLC: Global trends in the condom industry. Canal Fulton. 2005
Global Industry Analysts Inc: Condoms: A global strategic business report. San José. 2010
UNAIDS: UNAIDS policy position paper. Intensifying HIV Prevention. Geneva. 2005
UNICEF, UNICEF and WHO: Progress report. Towards universal access. Scaling up priority HIV/HIV interventions in the health sector. Geneva. 2010
UNAIDS: Monitoring the Declaration of Commitment on HIV/AIDS. Guidelines on construction of core indicators. Geneva. 2005
McCoy D, Kembhavi G, Patel J, Luintel A: The Bill & Melinda Gates Foundation's grant-making programme for global health. The Lancet. 2009, 9675: 1645-1653. 10.1016/S0140-6736(09)60571-7.
Fidler DP: Architecture amidst anarchy: Global health's quest for governance. Global Health Governance. 2007, I: 1-17.
Sridhar D: Seven challenges in international development assistance for health and ways forward. Global Health Governance. 2010, I: 1-12.
Beck E, Avila C, DeLay PR: International and domestic funding for HIV research: how much and how is it spent?. HIV Therapy. 2009, 3: 307-310. 10.2217/hiv.09.17.
Gómez E: What the United States can learn from Brazil in response to HIV/AIDS: international reputation and strategic centralization in a context of health policy devolution. Health Policy and Planning. 2010, 25: 529-541.
Askew I, Berer M: The contribution of sexual and reproductive health services to the fight against HIV. Reproductive Health Matters. 2003, 11: 51-73. 10.1016/S0968-8080(03)22101-7.
Mayhew SH: Donor dealings: The impact of international donor aid on sexual and reproductive health services. International Family Planning Perspectives. 2002, 28: 4-10.2307/3088225.